Study of Bortezomib,Lenalidomide,Dexamethasone & Elotuzumab in Newly Diagnosed MM
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Bortezomib
Related studies linked through entity extraction aliases.
Comparing and Combining Bortezomib and Mycophenolate in SSc Pulmonary Fibrosis
- Status
- COMPLETED
- Phase
- PHASE2
CyBorD vs. PAD in the Treatment of Newly Diagnosed Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE3
Combination of Ibrutinib and Bortezomib to Treat Patients With Mantle Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Melphalan and Bortezomib Prior to Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Bortezomib, Lenalidomide, and Dexamethasone in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE2
A Study of BBI608 in Adult Patients With Advanced, Refractory Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Bortezomib With Steroid Pulse Therapy for Acute Cellular Rejection in Kidney Transplantation
- Status
- UNKNOWN
- Phase
- PHASE3
Selinexor and Backbone Treatments of Multiple Myeloma Patients
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of Panobinostat in Combination With Bortezomib and Dexamethasone in Japanese Patients With Relapsed/Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
A Pharmacokinetic Study of Bortezomib in Taiwanese Participants With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE4
An Open-Label Study of a Novel JAK-inhibitor, INCB052793, Given to Patients With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety/Efficacy Study of LDE225 (Sonidegib) Plus Bortezomib in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE2
Bendamustine Hydrochloride, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Phase I Study of Bortezomib With G-CSF for Stem Cell Mobilization in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Dose Escalation of Velcade Daily Dose in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib in Rejection of Kidney Transplants
- Status
- COMPLETED
- Phase
- PHASE2
Nelfinavir as Bortezomib-sensitizing Drug in Patients With Proteasome Inhibitor-nonresponsive Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Difluoromethylornithine (DFMO) in Combination With Bortezomib for Relapsed or Refractory Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2